Dusre L, Covey J M, Collins C, Sinha B K
Clinical Pharmacology Branch, National Cancer Institute, Bethesda, MD 20892.
Chem Biol Interact. 1989;71(1):63-78. doi: 10.1016/0009-2797(89)90090-2.
Mitomycin C (MMC), a quinone-containing antitumor drug, has been shown to alkylate DNA and to form DNA cross-links. The ability of MMC to alkylate O6-guanine and to form interstrand cross-links (ISC) has been studied using Mer+ and Mer- human embryonic cells. Mer+ (IMR-90) cells have been reported to contain an O6-alkylguanine transferase enzyme and are, in general, more resistant to alkylating agents than the Mer- (VA-13) cell line, which is deficient in the repair of O6-lesions in DNA. Studies reported here show that MMC is more cytotoxic to VA-13 cells compared to IMR-90 cells. The alkaline elution technique was used to quantify MMC-induced ISC, and double strand breaks (DSB) in these cells. The drug-dependent formation of DSB was significantly lower in IMR-90 cells than in VA-13 cells. In contrast, no significant difference in cross-linking could be detected at the end of 2-h drug treatment. Although a small increase in cross-link frequency was observed in the VA-13 cell line relative to the IMR-90 cell line 6 h post drug treatment, it is not clear whether monoalkylated adducts at the O6-position are formed, and contribute to cross-link formation for differential cytotoxicity in VA-13 cells. Electron spin resonance and spin-trapping technique were used to detect the formation of hydroxyl radical from MMC-treated cells. Our studies show that MMC significantly stimulated the formation of hydroxyl radical in VA-13 cells, but not in the IMR-90 cells. The formation of the hydroxyl radical was inhibited by superoxide dismutase (SOD) and catalase. In addition, the presence of these enzymes partially protected VA-13 cells from MMC toxicity but not IMR-90 cells. Further studies indicated that the decreased free radical formation and resistance to MMC may be due to the increased activities of catalase and glutathione transferase in the IMR-90 cell line. These results suggest that MMC-dependent DNA damage (alkylation and DNA DSB) and the stimulation of oxy-radical formation may play critical roles in the determination of MMC-induced cell killing.
丝裂霉素C(MMC)是一种含醌的抗肿瘤药物,已被证明可使DNA烷基化并形成DNA交联。使用Mer +和Mer-人胚胎细胞研究了MMC使O6-鸟嘌呤烷基化并形成链间交联(ISC)的能力。据报道,Mer +(IMR-90)细胞含有一种O6-烷基鸟嘌呤转移酶,通常比Mer-(VA-13)细胞系对烷基化剂更具抗性,后者在修复DNA中的O6-损伤方面存在缺陷。此处报道的研究表明,与IMR-90细胞相比,MMC对VA-13细胞的细胞毒性更大。采用碱性洗脱技术对这些细胞中MMC诱导的ISC和双链断裂(DSB)进行定量。IMR-90细胞中药物依赖性DSB的形成明显低于VA-13细胞。相反,在2小时药物处理结束时,未检测到交联的显著差异。尽管在药物处理后6小时观察到VA-13细胞系相对于IMR-90细胞系的交联频率略有增加,但尚不清楚是否形成了O6位的单烷基化加合物,以及其是否有助于VA-13细胞中差异细胞毒性的交联形成。利用电子自旋共振和自旋捕获技术检测MMC处理细胞中羟基自由基的形成。我们的研究表明,MMC显著刺激了VA-13细胞中羟基自由基的形成,但在IMR-90细胞中未观察到。超氧化物歧化酶(SOD)和过氧化氢酶可抑制羟基自由基的形成。此外,这些酶的存在部分保护了VA-13细胞免受MMC毒性,但对IMR-90细胞无效。进一步的研究表明,自由基形成的减少和对MMC的抗性可能是由于IMR-90细胞系中过氧化氢酶和谷胱甘肽转移酶活性的增加。这些结果表明,MMC依赖性DNA损伤(烷基化和DNA DSB)以及氧自由基形成的刺激可能在MMC诱导的细胞杀伤作用中起关键作用。